57 reports

C IN 2018, DIABETES DRUGS WERE ADDED TO THE NEW LIST OF ## DRUGS THAT THE AUSTRALIAN GOVERNMENT ADDED TO THE PHARMACEUTICAL BENEFITS SCHEME, WHICH IS A PROGRAM THAT PROVIDES SUBSIDIZED PRESCRIPTION DRUGS.

  • Diabetes Monitoring
  • World
  • Market Size
  • Becton Property Group
  • Medtronic, Inc.
  • Blood Glucose Test Strips Market, Italy, Revenue in USD
  • HOSPTAL USE

Health insurance in Italy is primarily organized on a regional level through the nationally, which provides universal coverage, including the full funding of public doctors and prescription drugs.

  • Clinic
  • Diabetes Monitoring
  • North America
  • World
  • Forecast
  • Effective August 1, 2013 an annual quantity limit for blood glucose test strips has been

Prescription Drugs TABLE ##-##: BRITISH COLUMBIA - PRESCRIPTION DRUGS ANNUAL QUANTITY LIMIT, 2015 satisfied.

  • Diabetes Monitoring
  • Insulin Delivery
  • Canada
  • North America
  • Insulet Corporation
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2010 - 2017
  • 11.3 BLOOD GLUCOSE DEVICES (SMBG) MARKET AND FORECAST

Most people with diabetes are covered by the National Social Security System and pay ##% of the cost of their prescribed medication.

  • Diabetes Monitoring
  • Western Europe
  • World
  • Forecast
  • Roche Group
  • 10.3 Blood Glucose Devices (SMBG) Market and Forecast
  • Norway: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2010 - 2017

Note: ##.

  • Diabetes Monitoring
  • Northern Europe
  • Scandinavia
  • Western Europe
  • Forecast
  • 12.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2008 - 2016

Kuwait ##.

  • Diabetes Monitoring
  • Northern Europe
  • Western Europe
  • World
  • Forecast

IT OPERATES THROUGH FIVE BUSINESS SEGMENTS, NAMELY, PRESCRIPTION MEDICINES, ANIMAL HEALTH, BIOPHARMACEUTICALS, AND INDUSTRIAL CUSTOMERS, AND OTHER SALES.

  • Diabetes Monitoring
  • Canada
  • North America
  • AstraZeneca PLC
  • Becton Property Group

AT PRESENT, PRESCRIPTION DRUG ABUSE HAS INCREASED EXCEPTIONALLY HIGH WHERE IN MARCH 2014; THE U. S.

  • Diabetes Monitoring
  • World
  • Market Size
  • DexCom, Inc.
  • Medtronic, Inc.
  • 12.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND
  • NORWAY: FORECAST FOR SELF-MONITORING OF BLOOD GLUCOSE (SMBG) USERS (THOUSAND), 2016 - 2021

KUWAIT ##.

  • Diabetes Monitoring
  • Northern Europe
  • Western Europe
  • World
  • Forecast
  • NORWAY: FORECAST FOR SELF-MONITORING OF BLOOD GLUCOSE (SMBG) USERS (THOUSAND), 2016 - 2020
  • 11.3 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET AND

Most people with diabetes are covered by the National Social Security System and pay ##% of the cost of their prescribed medication.

  • Diabetes Monitoring
  • Northern Europe
  • Western Europe
  • Forecast
  • Roche Group
  • 10.3 Norway Self-Monitoring of Blood Glucose (SMBG) Market and
  • NORWAY: SELF-MONITORING OF BLOOD GLUCOSE (SMBG) MARKET (MILLION US$), 2007 - 2015

Most people with diabetes are covered by the National Social Security System and pay ##% of the cost of their prescribed medication.

  • Diabetes
  • Diabetes Monitoring
  • Northern Europe
  • Western Europe
  • Forecast

One unit refers to one monitor along with a sensor and a transmitter.

  • Diabetes Monitoring
  • Mexico
  • ARKRAY, Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.

One unit refers to one monitor along with a sensor and a transmitter.

  • Diabetes Monitoring
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.

One unit refers to one monitor along with a sensor and a transmitter.

  • Diabetes Monitoring
  • East Asia
  • ARKRAY, Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.

Title Page No. ##.

  • Diabetes Monitoring
  • World
  • Abbott
  • ARKRAY, Inc.
  • Bayer AG
  • EXAMPLE OF CURRENT REIMBURSEMENT PROGRAM, FOR CGM, IN THE US
  • US CGM REIMBURSEMENT POLICY REIMBURSEMENT POLICY

CONSUMER HEALTH FOCUSES ON NON-PRESCRIPTION MEDICINES, DIETARY SUPPLEMENTS AND DERMATOLOGY PRODUCTS.

  • Diabetes Monitoring
  • World
  • Forecast
  • Bayer AG
  • Medtronic, Inc.

Figure ##. ##: The US CGM Penetration of Type ## Diabetics (2010-2013) In the US, about ##-## thousand Type ## diabetics are active CGM users, accounting for ##. ##% of the diagnosed Type ## population in 2014.

  • Diabetes Monitoring
  • World
  • Abbott Laboratories, Inc.
  • Bayer AG
  • Roche Group

THE FDA GRANTED PRIORITY REVIEW FOR THE APPLICATION AND THE PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE IS DECEMBER ##, 2017.

  • Diabetes Monitoring
  • Genetic Testing
  • East Asia
  • Japan
  • Forecast

ONE UNIT REFERS TO ONE ML.

  • Diabetes Monitoring
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Forecast

THE PRESCRIPTION DRUG USER FEE ACT TARGET DATE FOR THE COMPLETION OF THE FDA' S REVIEW OF THE NDA IS JUNE ##, 2018.

  • Clinical Trial
  • Diabetes Monitoring
  • India
  • South Asia
  • Forecast

THE FDA HAS ASSIGNED A PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE OF AUGUST ##, 2017.

  • Allergy
  • Diabetes Monitoring
  • France
  • Western Europe
  • Forecast

ONE UNIT REFERS TO ONE ML.

  • Diabetes Monitoring
  • In Vitro Diagnostic Reagent
  • East Asia
  • South Korea
  • Forecast

INTERNATIONAL KEY BRANDS ACCOUNT FOR ##% OF NET SALES IN THE PRESCRIPTION MEDICINES BUSINESS.

  • Diabetes Monitoring
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Germany
  • Western Europe

ONE UNIT REFERS TO ONE ML.

  • Allergy
  • Diabetes Monitoring
  • Canada
  • North America
  • Forecast

IT IS ALSO REPORTED THAT OUT OF TOTAL NATIONAL HEALTH EXPENDITURES IN THE US, PRESCRIPTION DRUGS ##. ##% SHARE.

  • Diabetes Monitoring
  • North America
  • United States
  • Market Size
  • LifeScan, Inc.

Sales of prescription medicines (Pharmaceuticals) rose by ##. ## percent (Fx & portfolio adj. ) to ##. ## billion euros.

  • Diabetes Monitoring
  • Diagnostics
  • Medical Device
  • United States
  • Company

THE FDA HAS SET A PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE OF DEC. ##, 2017.

  • Diabetes Monitoring
  • In Vitro Diagnostic Reagent
  • Medical Device
  • North America
  • Forecast

THE FDA HAS SET A PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE OF DEC. ##, 2017.

  • Diabetes Monitoring
  • Diagnostics
  • Hospital
  • In Vitro Diagnostic Reagent
  • United States

Branded Prescription Drug Fee.

  • Diabetes Monitoring
  • Pharmaceutical
  • North America
  • United States
  • Pfizer Inc.

One unit refers to one reusable insulin pen.

  • Diabetes Monitoring
  • Medical Device
  • France
  • Western Europe
  • Sanofi S.A.